Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWGepotidacin is an inhibitor of bacterial topoisomerase II.1 It is active against 84 bacterial clinical isolates (MICs = 0.032-8 µg/ml) and vancomycin-resistant S. aureus (VRSA) and methicillin-resistant S. aureus (MRSA; MICs = 0.125 and 0.25 µg/ml, respectively).1,2 Gepotidacin reduces the number of lung colony-forming units (CFUs) in a mouse model of neutropenic S. aureus lung infection.2 Formulations containing gepotidacin have been used in the treatment of uncomplicated urinary tract infections.
WARNING This product is not for human or veterinary use.
1. In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob. Agents Chemother. 61(10), e01064-01017 (2017).
2. Pharmacodynamic profile of GSK2140944 against methicillin-